Search Medical Centers

Neolife Oncology Center

Location

Istanbul, Turkey

Neolife Oncology Center - Overview

IMPORTANT NOTICE:
Neolife Oncology Center is an Outpatient Oncology Hospital that does not perform surgeries.

For diagnosis and treatment of cancer, combining multi-disciplinary approach with modern healthcare services and state-of-the-art medical equipment and qualified team, Neolife Medical Center was put into service in 2010. For oncology procedures, our vision is being a reference institution for national and international centers, which meet national and international standards, and the institution is certified by ISO 9001-2008 in 2011 and JCI in 2013 and accordingly, our service quality is accredited.


Our center offers any and all diagnostic and therapeutic services with international patients from many countries of world based on its success in oncology treatment. International Patient Services render services round the clock to organize accommodation, translation and transport services for international patients. Our team deals with each patient professionally at all points, starting with first contact and arrival to Neolife in Istanbul and extending to diagnostic and therapeutic services and flight back to home country. The success profile achieved by Istanbul Neolife model in Turkey paved the way to establishment of second Neolife Medical Center in Bucharest, Romaniain 2013. A new center, also known as Neolife Vital was put into service Laşi,Romania in 2016. Those steps made us being one step closer to international targets.  Our target is to sustain and improve success, service quality and patient-physician satisfaction achieved to date. Awareness studies are continued by liaison offices established in nearby geography.

CENTERS OF EXCELLENCE

Radiotherapy and Radiosurgery

Neolife aims to provide healthcare in Oncology with the highest global standards in Diagnostic and Treatment Services especially in Radiotherapy and Radiosurgery.Radiotherapy and Radiosurgery have been rapidly evolving and we are proud to have the latest technologies in Radiotherapy and Radiosurgery as well as other technologies required for diagnostic and treatment services in Oncology.Radiotherapy can be used by itself or alongside with surgery and/or chemotherapy in cancer treatment. Compared with surgical treatment,radiotherapy can be a preferred treatment method as it protects healthy tissues and organs, therefore functionality loss is minimised. In radiotherapy, TrueBeam is superior to other radiotherapy devices, as it can perform radiotherapy and radiosurgery on the same platform by enabling the delivery of a higher dose in shorter times with higher performance in treatment processes, reduced duration and number of treatment sessions.

Treatment and Diagnostic Services

Neolife aims to provide healthcare in Oncology with the highest global standards in Diagnostic and Treatment Services especially in Radiotherapy and Radiosurgery. Radiotherapy and Radiosurgery have been rapidly evolving and we are proud to have the latest technologies in Radiotherapy and Radiosurgery as well as other technologies required for diagnostic and treatment services in Oncology. Radiotherapy can be used by itself or alongside with surgery and/or chemotherapy in cancer treatment.Compared with surgical treatment, radiotherapy can be a preferred treatment method as it protects healthy tissues and organs, therefore functionality loss is minimised. In radiotherapy, TrueBeam is superior to other radiotherapy devices, as it can perform radiotherapy and radiosurgery on the same platform by enabling the delivery of a higher dose in shorter times with higher performance in treatment processes, reduced duration and number of treatment sessions.

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT)

Stereotactic radiosurgery (SRS) is anon-surgical radiation treatment which is applied in order to eliminate functional anomalies and small tumors in brain. Stereotactic radiosurgery (SRS)is an extremely delicate form of a radiation treatment, which has been originally developed to treat functional anomalies and small tumors developing in brain. The purpose is to destroy the tumor and to apply the doses that will provide permanent local control.

This approach can improve the safety and allow improving the recovery of normal tissue between treatment sessions. For this reason, while the division of treatment into fractions allows sending high doses, it allows sustaining an acceptable safety profile. This operation is mostly named as fractional stereotactic radiotherapy (SRT) and means giving the typically focused radiation between two and five sessions.

SRS and SBRT are significant alternatives of invasive surgery for the patients which are not available to be taken into an operation and the tumors and anomalies which carry the following traits:


·      Difficult to access

·      Close to vitalorgans/anatomic areas

·      Movable areas inside body


SRS is used to treatthe following:

 

Many kinds of brain tumor which includes the following:


·       Benign and malign tumors

·       Primary and metastatic tumors

·       Single and more than one tumor

·       Postoperative residual tumor cells

·       Intracranial, orbital and skull base tumors

·       Arteriovenous malformations (AVMs), enlarged clue-shaped blood veins, which impair the normal blood flow and sometimes bleed.

·       Trigeminal neuralgia (facial nerve disorder), tremor and other similar neurological disorders


Today, SBRT is used in benign and malignant small and medium sized tumors and in the treatment of the common diseased areas,including the following:


·      Lungs

·      Liver

·      Abdomen

·      Vertebra

·      Prostate

·      Head and Neck

Brachytherapy


                      


In this of therapy the highest dose is deliveredto the intended body part, while the damage to nearby tissues is minimized. Asthe dose moves away from the source, the dose and its effect decrease quickly.Thus, while tumor gets the maximum dose, the healthy tissue around the tumor is exposed to a very low dose. Brachytherapy is an effective treatment especiallyfor gynecologic cancers, but it can also be used some tumors located indifferent body parts.

Imaging with GA-68 PSMA – Treatment of Prostate Cancer

There have been new developments in the diagnosis and treatment of Prostate Cancer, in recent years. The name of this important development is the PET/CT procedure which is performed with GA-68 PSMA.

 

The PSMA (Prostatic Specific Membrane Antigen) PET CT with Gallium 68 is the most sensitive and accurate method for diagnosing the prostate cancer which allows classification of prostate cancer at any stage.The PSMA PET CT with Gallium 68 allows for detailed assessment of localization of the tumor, it’s size and remote metastases in cases for patients for whom there remains a suspicion of prostate cancer, even if primary diagnostics gave negative results, or in case of males for whom there is probability of recurrence of prostate cancer.

 

Prostate cancer is the most common and fatal cancer type in men older than 50 years of age, after lung cancer.

 

PSMA, meaning Prostate Specific Membrane Antigen, is a molecule which has the trait of attaching to the receptors, on the surface of 95% of the prostate tumor cells. When we connect this molecule to a radioactive material, named GA-68, it becomes a radio pharmaceutical,extremely suitable for imaging. PSMA, marked with GA-68, allows the detection of recurrences, even at very low levels of PSA. We successfully use GA-68 PSA in diagnosis, staging, treatment planning and evaluation of response to therapy for prostate cancer.

GA-68-Dotatate and Treatment of Neuroendocrine Tumors

Neuro endocrine tumors is a disease group, which is rarely seen and can be originated from many organs and whose signs can be confused with other diseases; for this reason, it is a disease group which is very difficult to diagnose.

 

The sensitivity of the classical imaging methods like ultrasound, tomography and MRI is low especially in the diagnosis of small-sized neuro endocrine tumors. Neuro endocrine tumors are one of the ideal tumor types for molecular imaging. The existence of peptides which can attacht o the somatostatin receptors, known to be on the surfaces of neuro endocrine tumors, provides an opportunity for imaging these tumors.

 

On PET/CT imaging, made with GA-68 DOTATATE, itwas determined that 29% of patients’ stages changed and changes were made in75% patients’ treatment plans. The combination of the peptides, known to attach to the somatostatin receptors, located on the neuro endocrine tumor cells, with a radioactive component allows them to be visualized. DOTATAE, marked withGA-68, is one of the ideal agents, developed for this purpose. Especially in the treatment methods, performed with theranostic agents, the imaging of somatostatin receptors’ existence with GA-68 shows that this tumor type is also convenient for Rutesium-177 therapy, and this means the beginning of a new treatment method.

PET- CT Scan

Positron emission tomography (PET) is an imaging test which helps revealing how your tissues and organs function. PET scan uses a radioactive medicine (tracer) to display this activity.

 

PET scan is an effective way of examining the chemical activity in body parts. It can be beneficial in revealing or evaluating various diseases, including some cancers, heart diseases and brain disorders. The images, which are obtained from PET scan, provide different information from other scanning methods like computerized tomography (CT) or magnetic resonance imaging (MRG / MRI). A PET scan or combined CT-PET scan allows your physician to make the diagnosis of your disease better.


The cancer types which are very likely to be seen in PET scans include the following:

 

·      Brain Tumor

·      Breast Cancer

·      Cervix – Cervical Cancer

·      Colorectal Cancer

·      Esophagus Cancer

·      Head and Neck Cancer

·      Lung Cancer

·      Lymphoma

·      Melanoma

·      Pancreas Cancer

·      Prostate Cancer

·      Thyroid Cancer

Procedures by Numbers

Monthly Number of Patients that complete Radiotherapy, Radiosurgery and Brachytherapy is 130. 

Monthly Number of Total Chemotherapy Sessions is 450. 

Daily Number of Patients for Radiotherapy, Radiosurgery and Brachytherapy Procedures is about 90.

Supporting Groups and Counseling

Neolife provides support groups for patients and their family members, as well as psychological counselling by Psychiatrists and Psycho-oncologists.

International Patients

Neolife Center treats over 400 foreign patients per year, mainly from Eastern Europe and The Middle East. The staff can communicate with patients in English, Russian, Arabic, Bulgarian, Uzbek and Azerbaijani, and provide a variety of supporting services such as arranging the Visa, accommodation and flight arrangements, transportation to/from the airport and the hotel and coordinating the insurance.

Devices

  • Truebeam STX
  • Trilogy
  • PET-CT
  • Gamma Kamera
  • Brachytherapy
  • CT
  • MRI
  • 3D Mammography (Tomosyntesis)
  • Ultrasound
  • X-Ray

Applications

  • Radiotherapy
  • Radiosurgery (SRS)
  • Stereotactic Body Radiotherapy (SBRT)
  • IMRT
  • IGRT
  • 3D Conformal
  • RapidArc
  • Medical Check-Ups: “Personal Health Screening” or “Periodic General Health Check”
  • Electron Treatment
    • Chemotherapy
    • Immunotherapy
    • Cancer Diagnosis
    • Cancer Treatment
    • Ga68 Prostate Cancer Screening
    • Ga68 Neuroendocrine Tumor Screening





Specialties at Neolife Oncology Center

Services:

  • Transportation services
  • Personal escort available
  • Visa arrangements
  • Flight arrangements
  • Electronic medical records
  • Insurance coordination

Accommodations:

  • Accommodation arrangements

Certifications:

  • ISO 9001

Languages:

  • Arabic
  • English
  • Russian
  • Turkish
  • Albanian
  • Bosnian
  • Bulgarian
  • Macedonian
  • Romanian

Liability:

  • Doctors have liability insurance
  • Hospitals has liability insurance

Numbers:

  • Number of doctors: 20
  • Year established: 2010
Disclaimer:
The data provided in this page was provided by Neolife Oncology Center  or it's represetatives. last updated on Nov 26, 2019.
Please read our disclaimer. If you have found any errors or missing data, please inform us.

Copyright © 2008 - 2019 Health-Tourism.com, All Rights Reserved